Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAITHREYI CHAPPIDI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1710474473
CMS profile
8806397
Location
SAINT LOUIS, MO

General Payments · PY2020–2023

$839.45

  • Reported across 34 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$320.57

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $320.57 17

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $13.14 1
PY2021 $345.14 7
PY2022 $160.60 9
PY2023 $320.57 17

Payment records · PY2023 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2023 202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $15.44 02/02/2023 Food and Beverage Undisputed 01/23/2026 1016991415 CMS
Alexion Pharmaceuticals, Inc. $13.42 04/04/2023 Food and Beverage Undisputed 01/23/2026 1016975913 CMS
Amgen Inc. $18.42 01/09/2023 Food and Beverage Undisputed 01/23/2026 1020006887 CMS
Amneal Pharmaceuticals LLC $13.24 01/04/2023 Food and Beverage Undisputed 01/23/2026 1053483503 CMS
Amylyx Pharmaceuticals, Inc. $21.59 03/11/2023 Food and Beverage Undisputed 01/23/2026 1057675141 CMS
EMD Serono, Inc. $15.80 03/22/2023 Food and Beverage Undisputed 01/23/2026 1032490305 CMS
GENZYME CORPORATION $24.74 04/11/2023 Food and Beverage Undisputed 01/23/2026 1050012389 CMS
GENZYME CORPORATION $19.62 05/16/2023 Food and Beverage Undisputed 01/23/2026 1050012401 CMS
GENZYME CORPORATION $22.77 06/13/2023 Food and Beverage Undisputed 01/23/2026 1050012415 CMS
Horizon Therapeutics plc $13.27 01/18/2023 Food and Beverage Undisputed 01/23/2026 986969487 CMS
Lundbeck LLC $16.75 05/12/2023 Food and Beverage Undisputed 01/23/2026 1032194227 CMS
Mallinckrodt Hospital Products Inc. $24.49 04/20/2023 Food and Beverage Undisputed 01/23/2026 1042816105 CMS
Merz Pharmaceuticals, LLC $32.31 05/26/2023 Food and Beverage Undisputed 01/23/2026 1048293081 CMS
PFIZER INC. $15.55 02/03/2023 Food and Beverage Undisputed 01/23/2026 1049347601 CMS
PFIZER INC. $14.36 05/09/2023 Food and Beverage Undisputed 01/23/2026 1050692477 CMS
PFIZER INC. $16.05 06/03/2023 Food and Beverage Undisputed 01/23/2026 1049193747 CMS
SK Life Science, Inc. $22.75 01/24/2023 Food and Beverage Undisputed 01/23/2026 1054813073 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.